Lysosomal cholesterol-dependent anabolic regulation
Lysosomal cholesterol-dependent anabolic regulation
批准号:
10441692
负责人:
Ken Inoki
金额:
$52.17万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-04-01 至 2026-01-31
关键词:
AblationAcidsAdipose tissueAdultAmino AcidsAutophagocytosisBindingBinding ProteinsBrainCatabolic ProcessCell membraneCellsCholesterolComplexCuesDataDevelopmentDiabetes MellitusDiseaseDissociationEatingEventFRAP1 geneGTPase-Activating ProteinsGeneticGrowthGrowth FactorGuanineGuanine Nucleotide Exchange FactorsGuanosine Triphosphate PhosphohydrolasesHealthHigh Fat DietHumanIn VitroKnockout MiceLinkLipidsLipolysisLysosomal Storage DiseasesLysosomesMalignant NeoplasmsMembraneMembrane LipidsMembrane MicrodomainsMetabolicMetabolic DiseasesModelingMolecularMonomeric GTP-Binding ProteinsMusMutationNPC1 geneNeurodegenerative DisordersNiemann-Pick DiseasesObesityPathologicPathway interactionsPhenotypePhosphatidylinositol 4,5-DiphosphatePhosphotransferasesPhysiologicalPlayProcessProteinsRegulationResistanceRoleSignal TransductionSignaling ProteinSirolimusTestingTherapeuticThinnessTissuesWeight Gaincell growthcell growth regulationcholesterol-binding proteindesigndiet-induced obesityexperimental studyin vitro activityin vivoinhibitorinsulin sensitivitylipid metabolismlysosomal proteinsmalemethyl-beta-cyclodextrinmouse modelnucleotide metabolismorgan growthprotein complexrecruit
中文摘要
项目摘要
mTORC 1主要通过刺激细胞合成代谢过程,包括蛋白质,
脂质和核苷酸合成,以及抑制分解代谢过程如自噬。的异常活化
mTORC1信号传导与许多人类健康问题有关,包括癌症、神经退行性疾病、
疾病和代谢紊乱如肥胖症和糖尿病。mTORC1的活性受到以下因素的严格调节:
生长因子和多种细胞代谢因子,如氨基酸,其中氨基酸招募mTORC 1,
溶酶体通过Rag小GTPases活化,这是mTORC1活化的关键过程。虽然最近
研究揭示了氨基酸诱导溶酶体mTORC 1的分子机制,
定位及其通过Rag GTP酶的激活,它刚刚开始揭示细胞脂质,
胆固醇还调节mTORC1的活性。最近的一项研究表明,除了氨基酸,
溶酶体胆固醇也通过SLC38A9在增强Rag GTP酶的活性中起关键作用,
RagA/B的鸟嘌呤交换因子。我们发现BASP 1(Brain abundant signal membrane attached
信号蛋白1),一种已知的脂筏胆固醇/PIP 2结合蛋白,作为mTORC 1的关键刺激物起作用
活动在机制上,BASP 1以依赖于细胞胆固醇的方式在溶酶体上表达,
与RagA/B的GTOR活化蛋白复合物GATOR 1相互作用并抑制GATOR 1,从而刺激
细胞mTORC1活性。此外,BASP 1的消融在很大程度上减少了细胞中异常的mTORC 1激活。
缺乏功能性尼曼-匹克病,C1型(NPC1),一种溶酶体胆固醇输出蛋白。basp1
亚型小鼠显示发育生长减少,使人联想到mTOR亚型小鼠或小鼠
用mTORC1抑制剂雷帕霉素治疗。有趣的是,虽然成年Basp1亚型显示较高的胰岛素水平,
敏感性,他们表现出抵抗饮食引起的肥胖。我们认为BASP 1在以下方面起着至关重要的作用
通过感受溶酶体膜胆固醇刺激细胞mTORC 1活性以诱导合成代谢过程
或其他脂质,并有助于发育生长和饮食诱导的肥胖。本提案将阐明
溶酶体脂质增强BASP 1活性的分子机制以及BASP 1如何抑制GATOR 1
活性,并研究BASP 1在小鼠代谢紊乱中的病理生理学重要性
模型完成该项目确立了NPC1-BASP1-GATOR1-mTORC1通路在肿瘤发生中的作用。
调节细胞合成代谢的行动,并应产生有价值的信息,设置额外的实验,
探索代谢紊乱和其他疾病中溶酶体导向mTORC 1调节信号的这一新分支
mTORC 1相关的人类健康问题,包括神经退行性疾病、溶酶体贮积症,
和癌症
英文摘要
Project Summary
mTORC1 stimulates cell and organ growth mainly by stimulating cellular anabolic processes, including protein,
lipid, and nucleotide synthesis, and inhibiting catabolic processes such as autophagy. Aberrant activation of
mTORC1 signaling has been linked to many human health problems, including cancer, neurodegenerative
diseases, and metabolic disorders such as obesity and diabetes. The activity of mTORC1 is tightly regulated by
growth factors and multiple cellular metabolic cues such as amino acids, where amino acids recruit mTORC1 to
the lysosome through Rag small GTPases activation, a key process for mTORC1 activation. Although recent
studies have revealed the molecular mechanisms by which amino acids induce the lysosomal mTORC1
localization and its activation via Rag GTPases, it has just begun to uncover how cellular lipids such as
cholesterol also regulate the activity of mTORC1. A recent study demonstrated that, in addition to amino acids,
lysosomal cholesterol also plays a key role in enhancing the activity of Rag GTPases through SLC38A9, the
guanine exchange factor for RagA/B. We discovered that BASP1 (Brain abundant signal membrane attached
signal protein 1), a known lipid raft cholesterol/PIP2-binding protein, functions as a key stimulator of mTORC1
activity. Mechanistically, BASP1 expresses on the lysosome in a manner dependent on cellular cholesterol and
interacts with and inhibits GATOR1, the GTPase activating protein complex for RagA/B, thereby stimulating
cellular mTORC1 activity. In addition, ablation of BASP1 largely diminished aberrant mTORC1 activation in cells
lacking functional Niemann-Pick Disease, Type C1 (NPC1), a lysosomal cholesterol exporter. Basp1
hypomorphic mice display a reduced developmental growth, reminiscent of mTOR hypomorphic mice or mice
treated with the mTORC1 inhibitor, rapamycin. Interestingly, while adult Basp1 hypomorphs show higher insulin
sensitivity, they display resistance to diet-induced obesity. We propose that BASP1 plays a crucial role in
stimulating cellular mTORC1 activity to induce anabolic processes by sensing lysosomal membrane cholesterol
or other lipids and contribute to developmental growth and diet-induced obesity. This proposal will elucidate the
molecular mechanisms by which lysosomal lipids enhance BASP1 activity and how BASP1 inhibits GATOR1
activity and investigates the pathophysiological importance of BASP1 in developing metabolic disorders in mice
models. Completing this project establishes the role of the NPC1-BASP1-GATOR1-mTORC1 pathway in the
regulation of cellular anabolic actions and should yield valuable information to set additional experiments to
explore this new branch of lysosomal-oriented mTORC1 regulatory signaling in metabolic disorders and other
mTORC1-related human health problems, including neurodegenerative disease, lysosomal storage disorders,
and cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lysosomal cholesterol-dependent anabolic regulation
-
批准号:10589129
-
项目类别:
-
资助金额:$52.17万
-
财政年份:2022
-
负责人:Ken Inoki
-
依托单位:
Molecular mechanism of Rheb-dependent mTORC1 regulation
-
批准号:10641878
-
项目类别:
-
资助金额:$45.03万
-
财政年份:2022
-
负责人:Ken Inoki
-
依托单位:
Molecular mechanism of Rheb-dependent mTORC1 regulation
-
批准号:10416125
-
项目类别:
-
资助金额:$45.03万
-
财政年份:2022
-
负责人:Ken Inoki
-
依托单位:
Molecular mechanism of mTORC1-dependent translation and ribosome biogenesis
-
批准号:8887569
-
项目类别:
-
资助金额:$29.02万
-
财政年份:2015
-
负责人:Ken Inoki
-
依托单位:
Molecular mechanism of mTORC1-dependent translation and ribosome biogenesis
-
批准号:9050688
-
项目类别:
-
资助金额:$28.97万
-
财政年份:2015
-
负责人:Ken Inoki
-
依托单位:
Role of TSC-mTORC1 pathway for podocyte injury in diabetic nephropathy
-
批准号:8327837
-
项目类别:
-
资助金额:$31.41万
-
财政年份:2009
-
负责人:Ken Inoki
-
依托单位:
Role of TSC-mTORC1 pathway for podocyte injury in diabetic nephropathy
-
批准号:8527765
-
项目类别:
-
资助金额:$30.27万
-
财政年份:2009
-
负责人:Ken Inoki
-
依托单位:
Role of TSC-mTORC1 pathway for podocyte injury in diabetic nephropathy
-
批准号:7899912
-
项目类别:
-
资助金额:$35.11万
-
财政年份:2009
-
负责人:Ken Inoki
-
依托单位:
Role of TSC-mTORC1 pathway for podocyte injury in diabetic nephropathy
-
批准号:7740101
-
项目类别:
-
资助金额:$35.51万
-
财政年份:2009
-
负责人:Ken Inoki
-
依托单位:
Role of TSC-mTORC1 pathway for podocyte injury in diabetic nephropathy
-
批准号:8128712
-
项目类别:
-
资助金额:$31.46万
-
财政年份:2009
-
负责人:Ken Inoki
-
依托单位:
Role of mTORC1 pathway for podocyte injury in diabetic nephropathy
-
批准号:8756960
-
项目类别:
-
资助金额:$33.81万
-
财政年份:2009
-
负责人:Ken Inoki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
-
批准号:22007039
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王黎明
-
依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:朱义广
-
依托单位:
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
-
批准号:21372217
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:袁伟成
-
依托单位:
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
-
批准号:21172061
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2011
-
负责人:许新华
-
依托单位:
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
-
批准号:21176225
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:童少平
-
依托单位:
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
-
批准号:81072511
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:严江伟
-
依托单位:
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
-
批准号:30660215
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2006
-
负责人:王世范
-
依托单位: